l-carnitine cancer risk Serum carnitine and risk: a Mendelian randomization study identifying pancreatic cancer as a modifiable metabolic target | Discover Oncology Safety, Tolerability and Symptom Outcomes
Safety, Tolerability and Symptom Outcomes Associated with l Carnitine Supplementation in Patients with Cancer, Fatigue, and Carnitine Deficiency: A Phase I II Study ScienceDirect Trimethylamine N Oxide (TMAO) and cancer risk: Insights into a possible link ScienceDirect L Carnitine Carnitine, Choline, Cancer, & Cholesterol: The TMAO Connection The mechanism of acetyl L carnitine on colorectal cancer and its metabolomic study ScienceDirect Cancer and Cardiovascular Disease: Shared Risk Factors, Mechanisms, and Clinical Implications: JACC: CardioOncology State of the Art Review JACC: CardioOncology
Pay in 4 interest-free payments of $6.87 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13





